Publication Cover
New Genetics and Society
Critical Studies of Contemporary Biosciences
Volume 42, 2023 - Issue 1
537
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Strategies on personalized medicine and the power of the imagined public

, &
Article: e2260939 | Received 24 Mar 2023, Accepted 15 Sep 2023, Published online: 25 Sep 2023

References

  • Am, H., G. Solbu, and K. H. Sorensen. 2021. “The Imagined Scientist of Science Governance.” Social Studies of Science 51 (2): 277–297. https://doi.org/10.1177/0306312720962573.
  • Australian Health Ministers’ Advisory Council. 2017. National Health Genomics Policy Framework 2018-2021 (https://www1.health.gov.au/internet/main/publishing.nsf/Content/FD973B58DE82BCFFCA2581CC007D4682/$File/National-Health-Genomics-Policy-Framework.pdf.
  • Barnett, J., K. Burningham, G. Walker, and N. Cass. 2010. “Imagined Publics and Engagement Around Renewable Energy Technologies in the UK.” Public Understanding of Science 21 (1): 36–50. https://doi.org/10.1177/0963662510365663.
  • Bauer, S. 2014. “From Administrative Infrastructure to Biomedical Resource: Danish Population Registries, the “Scandinavian Laboratory,” and the “Epidemiologist's Dream”.” Science in Context 27 (2): 187–213. https://doi.org/10.1017/S0269889714000040.
  • Braun, V., and V. Clarke. 2006. “Using Thematic Analysis in Psychology.” Qualitative Research in Psychology 3 (2): 77–101. https://doi.org/10.1191/1478088706qp063oa.
  • Braun, V., and V. Clarke. 2019. “Reflecting on Reflexive Thematic Analysis.” Qualitative Research in Sport, Exercise and Health 11 (4): 589–597. https://doi.org/10.1080/2159676X.2019.1628806.
  • Brown, N., and M. Michael. 2003. “A Sociology of Expectations: Retrospecting Prospects and Prospecting Retrospects.” Technology Analysis & Strategic Management 15 (1): 3–18. https://doi.org/10.1080/0953732032000046024.
  • Burau, V., N. Nissen, M. D. Terkildsen, and U. Vaeggemose. 2021. “Personalised Medicine and the State: A Political Discourse Analysis.” Health Policy 125 (1): 122–129. https://doi.org/10.1016/j.healthpol.2020.10.005.
  • Busby, H., and P. Martin. 2006. “Biobanks, National Identity and Imagined Communities: The Case of UK Biobank.” Science as Culture 15 (3): 237–251. https://doi.org/10.1080/09505430600890693.
  • Coffey, A., and P. Atkinson. 1996. Making Sense of Qualitative Data: Complementary Research Strategies. Sage.
  • Deleuran Terkildsen, M., V. Burau, U. Væggemose, and N. Konstantin Nissen. 2020. “The Welfare State Driving “Me” and “We” Medicine – A Critical Discourse Analysis.” New Genetics and Society, https://doi.org/10.1080/14636778.2020.1755635.
  • Erikainen, S., and S. Chan. 2019. “Contested Futures: Envisioning “Personalized,” “Stratified,” and “Precision” Medicine.” New Genetics and Society 38 (3): 308–330. https://doi.org/10.1080/14636778.2019.1637720.
  • General Secretariat of the Council. 2015. Council conclusions on Personalised medicine for patients. http://data.consilium.europa.eu/doc/document/ST-15054-2015-INIT/en/pdf.
  • Gisle, S. 2018. “The Physiology of Imagined Publics: From a Deficit to an Ambivalence Model.” Science & Technology Studies 31 (2).
  • Gottweis, H. 2002. “The Governance of Genomics.” Critical Public Health 12 (3): 207–220. https://doi.org/10.1080/09581590210153344.
  • Health, A.-T. F. N. A. f. L. S. a. 2016. GENOMIC MEDICINE FRANCE 2025 (https://solidarites-sante.gouv.fr/IMG/pdf/genomic_medicine_france_2025.pdf.
  • Hoeyer, K. L. 2019. “Data as Promise – Reconfiguring Danish Public Health Through Personalized Medicine.” Social Studies of Science 49 (4): 531–555.
  • Hoeyer, K., S. Bauer, and M. Pickersgill. 2019. “Datafication and Accountability in Public Health: Introduction to a Special Issue.” Social Studies of Science 49 (4): 459–475. https://doi.org/10.1177/0306312719860202.
  • Jasanoff, S., & Kim, S.-H. (2015). Dreamscapes of Modernity: Sociotechnical Imaginaries and the Fabrication of Power. https://doi.org/10.7208/chicago/9780226276663.001.0001
  • Jensen, L. G., and M. N. Svendsen. 2021. “Personalised Medicine in the Danish Welfare State: Political Visions for the Public Good.” Critical Public Health, 1–12. https://doi.org/10.1080/09581596.2021.1937524.
  • Jones, M., and B. Salter. 2003. “The Governance of Human Genetics: Policy Discourse and Constructions of Public Trust.” New Genetics and Society 22 (1): 21–41. https://doi.org/10.1080/1463677032000069691.
  • Keogh, B. 2015. Personalised Medicine Strategy. NHS England Board. (https://www.england.nhs.uk/wp-content/uploads/2015/09/item5-board-29-09-15.pdf.
  • Maranta, A. G., Gisler Michael, and Christian Pohl. 2003. “The Reality of Experts and the Imagined Lay Person.” Acta Sociologica 46 (2).
  • Martin, P. A., and I. Turkmendag. 2021. “Thinking the Unthinkable: How Did Human Germline Genome Editing Become Ethically Acceptable?” New Genetics and Society 40 (4): 384–405. https://doi.org/10.1080/14699915.2021.1932451.
  • Prainsack, B. 2017. Personalized Medicine: Empowered Patients in the 21st Century. New York University Press.
  • Reardon, J. 2017. The Postgenomic Condition: Ethics, Justice, and Knowledge after the Genome. University of Chicago Press. https://doi.org/10.7208/9780226345192
  • Rodhouse, T. S. G. H., U. Pesch, E. H. W. J. Cuppen, and A. F. Correljé. 2021. “Public Agency and Responsibility in Energy Governance: A Q Study on Diverse Imagined Publics in the Dutch Heat Transition.” Energy Research & Social Science 77, https://doi.org/10.1016/j.erss.2021.102046.
  • Rommetveit, K., and B. Wynne. 2017. “Technoscience, Imagined Publics and Public Imaginations.” Public Understanding of Science 26 (2): 133–147. https://doi.org/10.1177/0963662516663057.
  • Ruppert, E. 2011. “Population Objects: Interpassive Subjects.” Sociology 45 (2): 218–233. https://doi.org/10.1177/0038038510394027.
  • Skovgaard, L. L., and K. Hoeyer. 2022. “Data Authority: Public Debate About Personalized Medicine in Denmark.” Public Understanding of Science 31 (5): 590–607. https://doi.org/10.1177/09636625221080535.
  • Svendsen, M. N., and L. E. Navne. 2022. “Citizen-Person: The “Me” in the “We” in Danish Precision Medicine.” Science, Technology, & Human Values, https://doi.org/10.1177/01622439221108535.
  • Tarkkala, H., I. Helén, and K. Snell. 2019. “From Health to Wealth: The Future of Personalized Medicine in the Making.” Futures 109: 142–152. https://doi.org/10.1016/j.futures.2018.06.004.
  • Tarkkala, H., and A. Tupasela. 2018. “Shortcut to Success? Negotiating Genetic Uniqueness in Global Biomedicine.” Social Studies of Science 48 (5): 740–761. https://doi.org/10.1177/0306312718801165.
  • Tupasela, A. 2021. Population as Brands – Marketing National Resources for Global Data Markets. Cham: Palgrave Macmillan. https://doi.org/10.1007/978-3-030-78578-9
  • Tupasela, A. 2022. “The Genetic Imagination: Imaging Populations and the Construction of Nationhood.” Finnishness, Whiteness and Coloniality, 19–40. https://doi.org/10.33134/hup-17-2.
  • Tutton, R. 2012. “Personalizing Medicine: Futures Present and Past.” Social Science & Medicine 75 (10): 1721–1728. https://doi.org/10.1016/j.socscimed.2012.07.031.
  • Walker, G., N. Cass, K. Burningham, and J. Barnett. 2010. “Renewable Energy and Sociotechnical Change: Imagined Subjectivities of ‘the Public’ and Their Implications.” Environment and Planning A: Economy and Space 42 (4): 931–947. https://doi.org/10.1068/a41400.
  • Webster, A. 2005. “Social Science and a Post-Genomic Future: Alternative Readings of Genomic Agency.” New Genetics and Society 24 (2): 227–238. https://doi.org/10.1080/14636770500184834.
  • Welsh, I., and B. Wynne. 2013. “Science, Scientism and Imaginaries of Publics in the UK: Passive Objects, Incipient Threats.” Science as Culture 22 (4): 540–566. https://doi.org/10.1080/14636778.2013.764072.